Avesthagen IPO: Review Analysis & Details

IPO's are now flocking the markets. Despite the no-so-good performance of Adani Power IPO and NHPC IPO, where investors could not pocket handsome returns, there are still a long list of companies willing to come to the stock market with their shares listing.
One such company which is willing to come out with an IPO or Initial Public Offering is the Bio Technlogy company called Avesthagen.
In this article, we will look at the review, analysis and fine details of the Avesthagen IPO and try to do the Review and analysis of Avesthagen IPO.
Some basic details first:
What is the issue size of the Avesthagen IPO?
The Avesthagen issue size is going to be for around 850-950 Crore Rupees.

How is the share distribution done?
The promoter Dr. Patell will continue to hold 32% of the company shares. There are 10 other investors who hold 28% shares. The investors include big names like Fidelity, ICICI Ventures and New York Life Investment Management India Fund.

How will the capital raised by Avesthagen IPO be used?
The use of capital will be for commercialization of the 40 products that the company is currently developing.

What is the price band of the Avesthagen IPO
The price band for shares of Avesthagen IPO is not yet decided.

What is the trading symbol & exchange for the Avesthagen IPO
No info is available about the trading symbol.

What are the IPO dates for Avesthagen IPO
The IPO for Avesthagen is expected to come out sometimes in first half of 2010, there are no concrete details available about the IPO dates.

Who are the underwriters of the Avesthagen IPO?
The book running lead managers and bankers are not yet decided.

What are the analysts recommendations for this IPO?
The company profile look good. Avesthagen expects to reach a turnover of Rs 100 crore from research and sale of nutrition products, among others. The company holds 560 patents and expects to license some of its plant-derived nutritional and therapeutic molecules and ingredients